Sponsors (36)
Introduced May 7, 2025 by Todd Young · Last progress May 7, 2025
The bill boosts near‑term R&D incentives and cash flow for startups and small R&D firms through expanded refundable credits, favorable computation options, and immediate expensing — at the cost of lower federal revenue, added compliance/admin burdens, and some uncertainty and unevenness in who benefits.
Small businesses and startups: lengthening the refundable startup credit window to 8 years, replacing the fixed $50,000 cap with an adjustable 'applicable amount,' consolidating the credit (removing quarterly caps), and adding favorable rate/election options and rules that exclude zero‑research years — together these changes increase access to refundable R&D credits and improve cash flow for early
R&D-performing businesses (including startups): restoring immediate expensing of research & experimental costs lets firms deduct R&E in the year paid or incurred, improving near‑term cash flow to reinvest or hire.
Eligible employers and tax administrators: treating the refundable credit as a single consolidated credit and removing quarterly caps simplifies administration and can speed access to refunds for qualifying employers.
All taxpayers: expanding refundable credits, lowering effective R&D rates for some firms, and allowing immediate expensing will reduce federal tax receipts and could increase budget deficits or create pressure for future tax increases or spending cuts.
Small businesses, employers, and tax practitioners: the bill introduces new elections, complex computations, requirements to track excluded years, and potential IRS approvals to change amortization methods, increasing compliance costs and administrative burden.
Small businesses and payroll processors: removing quarterly caps can produce large immediate refunds that complicate payroll tax accounting and cash‑flow forecasting for employers and their payroll service providers.
Based on analysis of 4 sections of legislative text.
Restores immediate expensing for R&D costs, revises refundable startup R&D credit rules (extend eligibility, change thresholds), and creates lower-rate options for qualified small businesses.
Restores immediate expensing for research and experimental (R&E) costs so businesses can deduct those R&E expenses in the year paid or incurred rather than amortizing them. It also changes how the refundable research credit works for startups and small firms: it extends startup eligibility from 5 to 8 years, modifies gross-receipts tests, replaces several literal $50,000 references with a single "applicable amount" placeholder, and creates a new set of special rules that lower certain credit rates for qualified small businesses while giving an alternate method to compute the credit lookback. The bill updates related tax-code cross references and interaction rules for capitalization, makes most changes effective for specified future taxable years (including a retroactive effective date for the expensing rule back to taxable years starting after Dec. 31, 2021), and alters refundable-credit calculations and elections that affect early-stage and small enterprises.